Gyre Therapeutics
GYRE
#5462
Rank
โ‚ฌ1.04 B
Marketcap
12,17 โ‚ฌ
Share price
6.01%
Change (1 day)
-13.29%
Change (1 year)

Revenue for Gyre Therapeutics (GYRE)

Revenue in 2024 (TTM): โ‚ฌ96.06 Million

According to Gyre Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.10 Billion. In 2023 the company made a revenue of โ‚ฌ0.10 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ14.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gyre Therapeutics from 2021 to 2024

20222023โ‚ฌ20Mโ‚ฌ40Mโ‚ฌ60Mโ‚ฌ80Mโ‚ฌ0.1Bโ‚ฌ0.12Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ96.06 M-11.66%
2023 โ‚ฌ0.10 B664.94%
2022 โ‚ฌ14.21 M5.49%
2021โ‚ฌ13.47 M